Morfina Basi (Morphine)

Morphine, the active ingredient in Morfina Basi, is an opioid analgesic presented as an injectable for epidural, intracerebroventricular, intra‑spinal use. It treats severe acute, postoperative and cancer‑related pain in adult patients. GNH USA supplies Morfina Basi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Morphine is an opioid analgesic used to manage pain pathways in several clinical settings.

Severe acute pain: provides rapid relief of intense pain episodes. Postoperative pain: reduces pain after surgical procedures. Cancer pain: controls persistent pain associated with malignant disease.

Morphine may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Nausea and vomiting: gastrointestinal upset often occurring early in therapy. - Constipation: reduced bowel motility leading to hard stools. - Drowsiness: mild sedation and reduced alertness. - Pruritus: itching, especially after epidural administration. - Dry mouth: decreased salivation. - Urinary retention: difficulty initiating urination.

Serious or Rare Side Effects: - Respiratory depression: marked reduction in breathing rate, potentially life‑threatening. - Hypotension: significant drop in blood pressure, especially with rapid administration. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Dependence and withdrawal: risk of physical dependence with prolonged use. - Neurotoxicity: rare spinal cord irritation after intrathecal use. - Cardiovascular collapse: profound circulatory failure in overdose.

Prior to initiating therapy, clinicians should evaluate patient‑specific risk factors and monitor for adverse events.

Assess pain level before use: ensure appropriate indication and dosing. Monitor respiratory function: watch for signs of depression, especially after dose changes. Avoid use in severe respiratory compromise: contraindicated in patients with uncontrolled hypoventilation. Adjust dose in renal/hepatic impairment: reduced clearance may increase exposure. Pregnancy Category C: weigh maternal benefit against fetal risk. Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Morphine interacts with several drug classes that can modify its safety or efficacy.

Major Interactions (Avoid): - CNS depressants: additive sedation and respiratory depression. - MAO inhibitors: risk of severe hypotension and serotonin syndrome. - SSRIs/SNRIs: potential for serotonin syndrome when combined.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole): increase morphine plasma levels. - CYP3A4 inducers (e.g., rifampin): reduce analgesic effect. - Diuretics: may enhance hypotensive response.